SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-17-000037
Filing Date
2017-07-12
Accepted
2017-07-12 17:24:13
Documents
5
Period of Report
2017-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-k2017publicoffering.htm 8-K 36808
2 UNDERWRITING AGREEMENT exh11.htm EX-1.1 200121
3 OPINION exh51.htm EX-5.1 12338
4 PRESS RELEASE exh991.htm EX-99.1 10372
5 PRESS RELEASE exh992.htm EX-99.2 11300
  Complete submission text file 0001561743-17-000037.txt   272035
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 17962274
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1